Black Diamond Therapeutics PEG Ratio

The latest PEG ratio for BDTX is 39.81. That is above the Healthcare sector average of 11.77. Investors often review this figure alongside Black Diamond Therapeutics's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, BDTX currently prints 39.81 for PEG ratio, while the sector average sits near 11.77. That is roughly 238.2% above the sector mean. Large gaps often invite a closer look at Black Diamond Therapeutics's growth, margins, and balance sheet.

A PEG ratio of 39.81 for Black Diamond Therapeutics is not 'good' or 'bad' on its own. Compare it with the peer average (11.77) and with BDTX's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting BDTX's PEG ratio (39.81), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Black Diamond Therapeutics's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.